Cullinan Therapeutics (CGEM) Stock
Cullinan Therapeutics (CGEM) closed at $9.28 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
33 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $9.28
- Nov 17, 2026
- Market cap
- $616.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 7.93 – 23.19
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Cullinan Therapeutics Inc scores 55/100. Mixed. Strongest on financial health and value, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 55 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecul…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Annexon IncANNX | 37 | $733.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
| Kura Oncology IncKURA | 30 | $651.4M |
| Olema Oncology Inc.OLMA | 56 | $644.8M |
| Arbutus Biopharma CorpABUS | 58 | $619.3M |
| Geron Corp.GERN | 55 | $606.8M |
| Climb Bio Inc.CLYM | 62 | $583.9M |
| Wave Life Sciences Inc.WVE | 54 | $566.0M |
| Sana Biotechnology IncSANA | 36 | $563.3M |
Common questions
What sector and industry is Cullinan Therapeutics in?
Cullinan Therapeutics is in the Healthcare sector and the Drugs industry.
What is Cullinan Therapeutics' Tenet Score?
Cullinan Therapeutics' Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




